Central Nervous System Stimulants: all 986 studies that test it

Page 4 of 10. Open to participants first (95), then studies with results posted, then the rest; newest registration first within each.

• Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderCompletedNCT01072630Phase 3Results posted
• Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue SyndromeCompletedNCT01071044Phase 4Results posted
• Effectiveness and Duration of Effect of Open Treatment in Attention Deficit Hyperactivity Disorder (ADHD) Patients Treated With Lisdexamfetamine Dimesylate(Vyvanse)CompletedNCT01070394Phase 4Results posted
• Diagnostic Utility of Attention Deficit Hyperactivity Disorder (ADHD) by Brain Activity Flow Patterns Analysis Using Evoked Response PotentialsCompletedNCT01063153Phase 4Results posted
• An Efficacy Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedNCT01060150Phase 4Results posted
• Magnetic Resonance Imaging Study of Lisdexamfetamine for Bipolar DepressionTerminatedNCT01051440Phase 4Results posted
• Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain TumorsCompletedNCT01032200Phase 2Results posted
• "Pilot Study of Armodafinil in Patients With Dementia With Lewy Bodies"CompletedNCT01023672Phase 4Results posted
• Vyvanse and Glucose Intolerance in Children With Attention Deficit Hyperactivity Disorder (ADHD) and ObesityTerminatedNCT01017263Phase 4Results posted
• Management of Insomnia in Breast Cancer PatientsCompletedNCT01011218Phase 2Results posted
• Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)CompletedNCT01010750Phase 1Results posted
• A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic MelanomaCompletedNCT01001299Phase 1Results posted
• Treatment of Traumatic Brain Injury (TBI)-Related Attention DeficitsTerminatedNCT01000064Phase 3Results posted
• Study of the Effect of Individualizing Daytrana Wear-times on Sleep in Children With ADHDCompletedNCT00989950Not applicableResults posted
• SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive DisorderCompletedNCT00985725Phase 2Results posted
• Study to Evaluate the Safety, Tolerability, and Efficacy of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain InjuryTerminatedNCT00983437Phase 3Results posted
• Impact of Armodafinil on Neurocognition and Cognitive Fatigue in Multiple Sclerosis (MS)CompletedNCT00981084Phase 2/3Results posted
• Treatment of Cocaine Dependence With LisdexamfetamineCompletedNCT00958282Phase 2Results posted
• Adult Study / OROS Methylphenidate Hydrochloride (HCL) (OROS MPH) in Adults With Attention Deficit Hyperactivity Disorder (ADHD)CompletedNCT00937040Phase 4Results posted
• Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative SymptomsCompletedNCT00922272Phase 2Results posted
• A Drug Interaction Study of SPD503 and Vyvanse Administered Alone and In Combination in Normal Healthy VolunteersCompletedNCT00919867Phase 1Results posted
• Exploratory Study of SPD489 in Adults With Major Depressive Disorder (MDD) as Augmentation Therapy to an AntidepressantCompletedNCT00905424Phase 2Results posted
• Quillivant Oral Suspension (Quillivant XR) in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD)CompletedNCT00904670Phase 3Results posted
• A Drug Interaction Study of SPD503 and Concerta Administered Alone and In Combination in Normal Healthy VolunteersCompletedNCT00901576Phase 1Results posted
• Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain InjuryTerminatedNCT00893789Phase 3Results posted
• Comparing the Effectiveness of New Versus Older Treatments for Attention Deficit Hyperactivity Disorder (The NOTA Study)CompletedNCT00889915Phase 4Results posted
• Efficacy of Caffeine Injection as an Adjuvant to Opioid Therapy in Cancer PainCompletedNCT00879775Phase 2Results posted
• Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity DisorderCompletedNCT00877487Phase 4Results posted
• Modafinil for Methamphetamine DependenceTerminatedNCT00859573Phase 2Results posted
• Pharmacotherapy & CM for Opioid and Cocaine DependenceCompletedNCT00838981Phase 1/2Results posted
• Dexmethylphenidate Hydrochloride Tablets Under Fasting ConditionsCompletedNCT00829712Phase 1Results posted
• Dexmethylphenidate Hydrochloride Tablets Under Non-Fasting ConditionsCompletedNCT00829673Phase 1Results posted
• Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other AgentsTerminatedNCT00825227Phase 2Results posted
• MRI and Neurodevelopment in Preterm Infants Following Administration of High-Dose CaffeineCompletedNCT00809055Phase 4Results posted
• Effect of Vyvanse on Driving in Young Adults With ADHDCompletedNCT00801229Phase 4Results posted
• A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions. An Extension Study of Protocol OB-303 (NCT00553787)CompletedNCT00796367Phase 3Results posted
• Double-blind, Placebo-controlled, Randomised Withdrawal, Extension, Safety and Efficacy Study of LDX in Children and Adolescents Aged 6-17CompletedNCT00784654Phase 3Results posted
• Study to Evaluate the Efficacy and Quality of Life of Long-Acting Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD)CompletedNCT00783835Phase 4Results posted
• Evaluating the Methylphenidate Patch to Treat Former Stimulant Users With ADHDCompletedNCT00780208Not applicableResults posted
• Compare Subjective Drug Liking & Pharmacokinetics of Vyvanse™ and ADDERALL XR® When Administered as an Oral SolutionTerminatedNCT00776555Phase 1Results posted
• Efficacy and Safety of Dex-Methylphenidate Extended Release 30 mg Versus 20 mg in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting.CompletedNCT00776009Phase 4Results posted
• Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With SchizophreniaCompletedNCT00772005Phase 2Results posted
• A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant GliomasCompletedNCT00766467Phase 2Results posted
• Vyvanse Adolescent Open-Label Safety and Efficacy Extension StudyCompletedNCT00764868Phase 3Results posted
• Randomized, Double-blind Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17CompletedNCT00763971Phase 3Results posted
• Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag DisorderCompletedNCT00758498Phase 3Results posted
• The Impact of Osmotic Release Oral Delivery System Methylphenidate (OROS MPH) Upon Family of Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)CompletedNCT00758160Phase 4Results posted
• Long Acting Stimulant Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Young ChildrenCompletedNCT00754208Phase 4Results posted
• Cardiovascular Study of Lisdexamfetamine in Healthy and Hypertensive Attention Deficit Hyperactivity Disorder AdultsCompletedNCT00753012Phase 4Results posted
• Effects of Modafinil in Methamphetamine DependenceCompletedNCT00751023Phase 4Results posted
• Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTCCompletedNCT00746733Phase 1Results posted
• A Study of VI-0521 for the Treatment of Obstructive Sleep Apnea / Hypopnea Syndrome in Obese AdultsCompletedNCT00745251Phase 1/2Results posted
• Open-Label, Multiple-Dose, Non-Randomized Study to Assess Drug-Drug Interactions of Proellex® in Female SubjectsCompletedNCT00741468Phase 1Results posted
• Open-Label Study to Evaluate the Long-Term Safety and Efficacy of VI-0521 in Type 2 Diabetic AdultsTerminatedNCT00737633Phase 2Results posted
• Effectiveness of Armodafinil for Treating Fatigue in Adults With HIV/AIDSCompletedNCT00737204Phase 4Results posted
• Attention Deficit Hyperactivity Disorder (ADHD) Smoking Cessation StudyCompletedNCT00736255Not applicableResults posted
• Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedNCT00735371Phase 3Results posted
• Caffeine and CocaineCompletedNCT00733993Phase 1/2Results posted
• The Effects of Vyvanse(TM) on Brain Hemodynamics and ReadingCompletedNCT00733356Phase 4Results posted
• Neurobiological Principles Applied to the Rehabilitation of Stroke PatientsCompletedNCT00715520Not applicableResults posted
• Study to Evaluate Armodafinil Treatment in Improving Prefrontal Cortical Activation and Working Memory PerformanceCompletedNCT00711516Phase 4Results posted
• Modafinil Effects on Cognition in Schizophrenia PatientsCompletedNCT00711464Phase 4Results posted
• Safety and Efficacy Workplace Environment Study of Lisdexamfetamine Dimesylate (LDX) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)CompletedNCT00697515Phase 3Results posted
• An Eight Week, Double-Blind Efficacy Study of Armodafinil Augmentation to Alleviate Fibromyalgia FatigueCompletedNCT00678691Phase 4Results posted
• Modafinil Treatment for Sleep/Wake Disturbances in Older AdultsTerminatedNCT00626210Phase 4Results posted
• Modafinil for Treatment of Fatigue in ALS PatientsCompletedNCT00614926Phase 4Results posted
• Stress and Medication Effects on Cocaine Cue ReactivityCompletedNCT00613015Phase 2Results posted
• Effectiveness of Methylphenidate in Improving Cognition and Function in Older Adults With DepressionCompletedNCT00602290Phase 4Results posted
• A VI-0521 Study to Evaluate the Long-term Safety and Efficacy in Type 2 Diabetic AdultsCompletedNCT00600067Phase 2Results posted
• Proton Magnetic Spectroscopy in Children and Adolescents With ADHD Before and After Treatment With OROS MethylphenidateCompletedNCT00593112Phase 4Results posted
• PET Study Examining the Dopaminergic Activity of Armodafinil in AdultsCompletedNCT00592943Phase 1/2Results posted
• Use of Modafinil in the Treatment of TinnitusTerminatedNCT00591019Phase 1Results posted
• Study of Medication Patch to Treat Children Ages 6-12 With ADHDCompletedNCT00586157Phase 4Results posted
• Modafinil, Sleep, and Cognition in Cocaine DependenceCompletedNCT00582491Not applicableResults posted
• Learning Impairments Among Survivors of Childhood CancerCompletedNCT00576472Phase 4Results posted
• The Reinforcing Mechanisms of Smoking in Adult ADHDCompletedNCT00573859Phase 1/2Results posted
• Pilot Study of Vyvanse™ In ADHD Adolescents at Risk for Substance AbuseCompletedNCT00573534Phase 4Results posted
• Safety and Tolerability of Modafinil for Methamphetamine DependenceCompletedNCT00569374Phase 2Results posted
• A Study of Dex-methylphenidate Extended Release in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedNCT00564954Phase 4Results posted
• A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity in AdultsCompletedNCT00563368Phase 3Results posted
• Study of VI-0521 Compared to Placebo in Treatment of Obesity in AdultsCompletedNCT00554216Phase 3Results posted
• Study of VI-0521 Compared to Placebo in Treatment of Diabetes and Obesity in Adults With Obesity-Related Co-Morbid ConditionsCompletedNCT00553787Phase 3Results posted
• Quetiapine and Concerta in the Treatment for ADHD and Aggressive Behavior.CompletedNCT00550147Phase 2Results posted
• Testing Methylphenidate for Smoking AbstinenceCompletedNCT00549640Phase 2Results posted
• Role of Apathy in the Effectiveness of Weight Loss InterventionsCompletedNCT00548652Not applicableResults posted
• A Pilot Study of Daytrana TM in Children With Autism Co-Morbid for Attention Deficit Hyperactivity Disorder (ADHD) SymptomsCompletedNCT00541346Phase 3Results posted
• Study of the Effects of Osmotic-Release Oral System (OROS) Methylphenidate (Concerta) on Attention and MemoryCompletedNCT00530257Phase 4Results posted
• Methylphenidate for the Treatment of Gait Impairment in Parkinson's DiseaseCompletedNCT00526630Phase 4Results posted
• Phase 2, Multi-Center Trial of Modafinil for Methamphetamine DependenceCompletedNCT00520286Phase 2Results posted
• Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and DepressionCompletedNCT00518986Phase 4Results posted
• Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer PatientsTerminatedNCT00516269Phase 3Results posted
• Methylphenidate Transdermal System (MTS) in the Treatment of Adult ADHDCompletedNCT00506285Phase 3Results posted
• Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHDCompletedNCT00501293Phase 3Results posted
• A Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD)CompletedNCT00500149Phase 3Results posted
• Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHDCompletedNCT00500071Phase 4Results posted
• Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHDCompletedNCT00499863Phase 3Results posted
• The Discriminative Effects of Tramadol in HumansCompletedNCT00499746Phase 1/2Results posted
• Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled StudyCompletedNCT00495820Phase 4Results posted
• Efficacy and Safety of Armodafinil as Adjunctive Therapy in Schizophrenic Adults With Cognitive DeficitsCompletedNCT00487942Phase 2Results posted
• Study of VI-0521 Compared to Placebo in the Glycemic Management of Obese DiabeticsCompletedNCT00486291Phase 2Results posted

← Central Nervous System Stimulants overview